Nanobac Pharmaceuticals, Incorporated
NNBP
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Net Income | 10.43% | -6.17% | 48.65% | -159.24% | -50.86% |
| Total Depreciation and Amortization | -3.07% | -2.80% | -2.12% | -38.04% | -39.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.61% | 215.44% | -92.84% | 346.82% | 438.30% |
| Change in Net Operating Assets | 103.62% | 298.66% | 659.02% | 394.16% | 822.03% |
| Cash from Operations | 83.53% | 69.18% | 60.41% | 42.17% | -11.01% |
| Capital Expenditure | 100.00% | 100.00% | 100.00% | 60.53% | -33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -50.77% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 1,966.67% | -- |
| Cash from Investing | 96.34% | 55.56% | 100.00% | -- | -583.33% |
| Total Debt Issued | -75.27% | -59.83% | -8.04% | -80.29% | 12.20% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -75.27% | -59.83% | -3.28% | -79.64% | 13.26% |
| Foreign Exchange rate Adjustments | -42.35% | -100.53% | 296.30% | -36.21% | -179.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.63% | 99.61% | 98.79% | -105.40% | -2,125.00% |